Location History:
- Uttar Pradesh, IN (2010)
- Noida, IN (2012)
Company Filing History:
Years Active: 2010-2012
Title: Soumendu Paul: Innovator in Pharmaceutical Chemistry
Introduction
Soumendu Paul is a notable inventor based in Noida, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds and processes. His work has led to the filing of multiple patents, showcasing his innovative approach to solving complex chemical challenges.
Latest Patents
Soumendu Paul holds 2 patents that reflect his expertise in pharmaceutical processes. His latest patents include:
1. **Process for producing 1-benzyl-4-[5,6-dimethoxy-1-indanon-2-yl)methyl] piperidine or its salt thereof via novel intermediate** - This patent discloses a process for producing 1-benzyl-4-[(5,6-dimethoxy-1-indanon-2yl)methyl]piperidine or its salt using novel intermediates.
2. **Polymorphic forms of fluvastatin sodium and process for preparing the same** - This patent reveals novel polymorphic forms of Fluvastatin sodium, characterized by their powder X-ray diffraction patterns, infrared absorption spectrums, thermo gravimetric analysis, and differential scanning calorimetry. The processes for preparing these polymorphic forms, as well as an amorphous form of Fluvastatin sodium, are also disclosed.
Career Highlights
Soumendu Paul is currently associated with Jubilant Organosys Limited, a prominent player in the pharmaceutical industry. His role involves research and development, where he applies his knowledge to create innovative solutions in drug formulation and synthesis.
Collaborations
Throughout his career, Soumendu has collaborated with esteemed colleagues such as Rajesh Kumar Thaper and Shailendra Kumar Dubey. These collaborations have further enriched his research and contributed to the advancement of pharmaceutical sciences.
Conclusion
Soumendu Paul's contributions to pharmaceutical chemistry through his patents and collaborative efforts highlight his role as an innovator in the field. His work continues to influence the development of new therapeutic agents and processes.